Healthcare entity

Codexis

Company CDXS

Every one of those 1 sits in a single category, health-it. Of the tracked stories, 1 of 1 also mention Biote, the most common co-covered peer. Source depth averages 9 original sources per story, versus 3.3 across the same-window beat baseline.

Last mentioned: Mar 24, 2026

Entity pulse

Recent coverage · Codexis

1 story
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Codexis

Every one of those 1 sits in a single category, health-it. Of the tracked stories, 1 of 1 also mention Biote, the most common co-covered peer. Source depth averages 9 original sources per story, versus 3.3 across the same-window beat baseline. At 6, the average consequence score sits above the same-window beat average of 5.9. We currently track 1 Healthcare story that mention Codexis, all published on March 12, 2026.

Stories tracked
1
Sources per story
9

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Codexis. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. NXT 41X Launch

    Anticipated commercial launch of Elutia's next-gen drug-eluting biomaterial.

  2. Bumble 2.0 Launch

    Targeted launch of AI-enabled platform experience.

  3. Codexis CDMO Expansion

    Announced three major CDMO agreements with Bachem, Nitto Avecia, and Axolabs.

  4. Elutia FDA Milestone

    Expected FDA submission for NXT 41X product line.

  5. Elutia Divestiture

    Completed $88M sale of bioenvelope business to Boston Scientific.

Stories mentioning Codexis 1

Health IT Positive

MedTech and Life Sciences Pivot Toward AI Efficiency and Asset Optimization

The Q4 2025 earnings cycle for mid-cap healthcare and life sciences firms reveals a strategic shift toward high-margin AI integration and portfolio streamlining. Companies like Elutia and Codexis are leveraging divestitures and technology transfers to shore up balance sheets, while AI-driven productivity gains are becoming a primary differentiator in clinical and operational workflows.

9 sources

Codexis is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.